发布求助
文献互助 智能选刊 最新文献

Evidence-based Oncology最新文献

筛选
英文 中文
Combined intra-arterial and intravenous chemotherapy may prolong time to recurrence after hepatic resection of colorectal cancer 动脉静脉联合化疗可延长结直肠癌肝切除术后的复发时间
Evidence-based Oncology Pub Date : 2002-12-01 DOI: 10.1054/EBON.2002.0049
A. Venook
{"title":"Combined intra-arterial and intravenous chemotherapy may prolong time to recurrence after hepatic resection of colorectal cancer","authors":"A. Venook","doi":"10.1054/EBON.2002.0049","DOIUrl":"https://doi.org/10.1054/EBON.2002.0049","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"8 1","pages":"159-161"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87657878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluoxetine may reduce hot flashes in women with a history of breast cancer 氟西汀可以减少有乳腺癌病史的女性的潮热
Evidence-based Oncology Pub Date : 2002-12-01 DOI: 10.1054/ebon.2002.0050
Paula Amato MD , Janet S Carpenter PhD, RN (Assistant Professor, Deputy Director)
{"title":"Fluoxetine may reduce hot flashes in women with a history of breast cancer","authors":"Paula Amato MD , Janet S Carpenter PhD, RN (Assistant Professor, Deputy Director)","doi":"10.1054/ebon.2002.0050","DOIUrl":"https://doi.org/10.1054/ebon.2002.0050","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 4","pages":"Pages 182-184"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0050","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71740196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Combined intra-arterial and intravenous chemotherapy may prolong time to recurrence after hepatic resection of colorectal cancer 动脉静脉联合化疗可延长结直肠癌肝切除术后的复发时间
Evidence-based Oncology Pub Date : 2002-12-01 DOI: 10.1054/ebon.2002.0049
Alan Venook (Professor, Director)
{"title":"Combined intra-arterial and intravenous chemotherapy may prolong time to recurrence after hepatic resection of colorectal cancer","authors":"Alan Venook (Professor, Director)","doi":"10.1054/ebon.2002.0049","DOIUrl":"https://doi.org/10.1054/ebon.2002.0049","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 4","pages":"Pages 159-161"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0049","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71755824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laser therapy followed by brachytherapy may be more effective than laser therapy alone for palliating advanced malignant dysphagia 在缓解晚期恶性吞咽困难方面，激光治疗加近距离放射治疗可能比单纯激光治疗更有效
Evidence-based Oncology Pub Date : 2002-12-01 DOI: 10.1054/ebon.2002.0058
HJ Stein MD
{"title":"Laser therapy followed by brachytherapy may be more effective than laser therapy alone for palliating advanced malignant dysphagia","authors":"HJ Stein MD","doi":"10.1054/ebon.2002.0058","DOIUrl":"https://doi.org/10.1054/ebon.2002.0058","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 4","pages":"Pages 171-172"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0058","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71719123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heparin alone is as effective as heparin plus ursodiol for preventing hepatic veno-occlusive disease after hematopoietic stem cell transplantation 在预防造血干细胞移植后肝静脉闭塞性疾病方面，单独使用肝素与肝素加熊二醇一样有效
Evidence-based Oncology Pub Date : 2002-12-01 DOI: 10.1054/EBON.2002.0055
K. Ohashi
{"title":"Heparin alone is as effective as heparin plus ursodiol for preventing hepatic veno-occlusive disease after hematopoietic stem cell transplantation","authors":"K. Ohashi","doi":"10.1054/EBON.2002.0055","DOIUrl":"https://doi.org/10.1054/EBON.2002.0055","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"115 22 1","pages":"157-158"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84206627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peglyated asparaginase reduces high-titer anti-enzyme antibodies compared with E. Coli asparaginase for children with acute lymphoblastic leukemia 与大肠杆菌天冬酰胺酶相比，聚乙二醇天冬酰胺酶可降低急性淋巴细胞白血病儿童的高滴度抗酶抗体
Evidence-based Oncology Pub Date : 2002-12-01 DOI: 10.1054/EBON.2002.0042
H. Müller
{"title":"Peglyated asparaginase reduces high-titer anti-enzyme antibodies compared with E. Coli asparaginase for children with acute lymphoblastic leukemia","authors":"H. Müller","doi":"10.1054/EBON.2002.0042","DOIUrl":"https://doi.org/10.1054/EBON.2002.0042","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"46 1","pages":"150-152"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78663361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Four weeks of enoxaparin reduces venous thrombosis after abdominal cancer compared with 1 week of treatment 与1周治疗相比，4周依诺肝素治疗可减少腹腔肿瘤后静脉血栓形成
Evidence-based Oncology Pub Date : 2002-12-01 DOI: 10.1054/EBON.2002.0043
H. Bounameaux
{"title":"Four weeks of enoxaparin reduces venous thrombosis after abdominal cancer compared with 1 week of treatment","authors":"H. Bounameaux","doi":"10.1054/EBON.2002.0043","DOIUrl":"https://doi.org/10.1054/EBON.2002.0043","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"59 1","pages":"175-176"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74374104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heparin alone is as effective as heparin plus ursodiol for preventing hepatic veno-occlusive disease after hematopoietic stem cell transplantation 在预防造血干细胞移植后肝静脉闭塞性疾病方面，单独使用肝素与肝素加熊二醇一样有效
Evidence-based Oncology Pub Date : 2002-12-01 DOI: 10.1054/ebon.2002.0055
Kazuteru Ohashi MD, PhD, FACP, FJSIM
{"title":"Heparin alone is as effective as heparin plus ursodiol for preventing hepatic veno-occlusive disease after hematopoietic stem cell transplantation","authors":"Kazuteru Ohashi MD, PhD, FACP, FJSIM","doi":"10.1054/ebon.2002.0055","DOIUrl":"https://doi.org/10.1054/ebon.2002.0055","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 4","pages":"Pages 157-158"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0055","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71778680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anastrozole is as effective as tamoxifen as first-line treatment for hormone receptor positive advanced breast cancer 阿那曲唑作为激素受体阳性晚期乳腺癌的一线治疗与他莫昔芬一样有效
Evidence-based Oncology Pub Date : 2002-12-01 DOI: 10.1054/ebon.2002.0044
Kathy D Miller MD
{"title":"Anastrozole is as effective as tamoxifen as first-line treatment for hormone receptor positive advanced breast cancer","authors":"Kathy D Miller MD","doi":"10.1054/ebon.2002.0044","DOIUrl":"https://doi.org/10.1054/ebon.2002.0044","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 4","pages":"Pages 177-178"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0044","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71808032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-dose radiotherapy does not increase survival compared with standard-dose radiotherapy in people with esophageal cancer 与标准剂量放疗相比，高剂量放疗不能提高食管癌患者的生存率
Evidence-based Oncology Pub Date : 2002-12-01 DOI: 10.1054/ebon.2002.0052
Vinay Sharma (Associate Professor)
{"title":"High-dose radiotherapy does not increase survival compared with standard-dose radiotherapy in people with esophageal cancer","authors":"Vinay Sharma (Associate Professor)","doi":"10.1054/ebon.2002.0052","DOIUrl":"https://doi.org/10.1054/ebon.2002.0052","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 4","pages":"Pages 168-170"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0052","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71824448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信